Literature DB >> 26438729

Immunity and immune modulation in Trypanosoma cruzi infection.

Fabíola Cardillo1, Rosa Teixeira de Pinho2, Paulo Renato Zuquim Antas2, José Mengel3.   

Abstract

Chagas disease is caused by the protozoan Trypanosoma cruzi. The parasite reaches the secondary lymphoid organs, the heart, skeletal muscles, neurons in the intestine and esophagus among other tissues. The disease is characterized by mega syndromes, which may affect the esophagus, the colon and the heart, in about 30% of infected people. The clinical manifestations associated with T. cruzi infection during the chronic phase of the disease are dependent on complex interactions between the parasite and the host tissues, particularly the lymphoid system that may either result in a balanced relationship with no disease or in an unbalanced relationship that follows an inflammatory response to parasite antigens and associated tissues in some of the host organs and/or by an autoimmune response to host antigens. This review discusses the findings that support the notion of an integrated immune response, considering the innate and adaptive arms of the immune system in the control of parasite numbers and also the mechanisms proposed to regulate the immune response in order to tolerate the remaining parasite load, during the chronic phase of infection. This knowledge is fundamental to the understanding of the disease progression and is essential for the development of novel therapies and vaccine strategies. © FEMS 2015. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Trypanosoma cruzi; gamma delta T cell; interleukin-17; memory T cell; myeloid-derived suppressor cell (MDSC); regulatory T cell

Mesh:

Year:  2015        PMID: 26438729      PMCID: PMC4626602          DOI: 10.1093/femspd/ftv082

Source DB:  PubMed          Journal:  Pathog Dis        ISSN: 2049-632X            Impact factor:   3.166


  107 in total

1.  B cells modulate T cells so as to favour T helper type 1 and CD8+ T-cell responses in the acute phase of Trypanosoma cruzi infection.

Authors:  Fabiola Cardillo; Edilberto Postol; Jorge Nihei; Luiz S Aroeira; Auro Nomizo; José Mengel
Journal:  Immunology       Date:  2007-07-16       Impact factor: 7.397

2.  A novel subset of adult gamma delta thymocytes that secretes a distinct pattern of cytokines and expresses a very restricted T cell receptor repertoire.

Authors:  V Azuara; J P Levraud; M P Lembezat; P Pereira
Journal:  Eur J Immunol       Date:  1997-02       Impact factor: 5.532

Review 3.  Chagas' disease and Chagas' syndromes: the pathology of American trypanosomiasis.

Authors:  F Köberle
Journal:  Adv Parasitol       Date:  1968       Impact factor: 3.870

4.  T-cell repertoire analysis in acute and chronic human Chagas' disease: differential frequencies of Vbeta5 expressing T cells.

Authors:  R P Costa; K J Gollob; L L Fonseca; M O Rocha; A C Chaves; N Medrano-Mercado; T C Araújo-Jorge; P R Antas; D G Colley; R Correa-Oliveira; G Gazzinelli; J Carvalho-Parra; W O Dutra
Journal:  Scand J Immunol       Date:  2000-05       Impact factor: 3.487

5.  IL-10 limits parasite burden and protects against fatal myocarditis in a mouse model of Trypanosoma cruzi infection.

Authors:  Ester Roffê; Antonio Gigliotti Rothfuchs; Helton C Santiago; Ana Paula M P Marino; Flavia L Ribeiro-Gomes; Michael Eckhaus; Lis R V Antonelli; Philip M Murphy
Journal:  J Immunol       Date:  2011-12-12       Impact factor: 5.422

6.  Endogenous CD4(+) CD25(+) regulatory T cells have a limited role in the control of Trypanosoma cruzi infection in mice.

Authors:  Joshua Kotner; Rick Tarleton
Journal:  Infect Immun       Date:  2006-11-13       Impact factor: 3.441

7.  Cutting edge: dysfunctional CD8+ T cells reside in nonlymphoid tissues during chronic Trypanosoma cruzi infection.

Authors:  Jennifer K Leavey; Rick L Tarleton
Journal:  J Immunol       Date:  2003-03-01       Impact factor: 5.422

8.  Dual role for nitric oxide in paracoccidioidomycosis: essential for resistance, but overproduction associated with susceptibility.

Authors:  Flávia R F Nascimento; Vera L G Calich; Dunia Rodríguez; Momtchilo Russo
Journal:  J Immunol       Date:  2002-05-01       Impact factor: 5.422

9.  Do self-heart-reactive T cells expand in Trypanosoma cruzi-immune hosts?

Authors:  C R Gattass; M T Lima; A F Nóbrega; M A Barcinski; G A Dos Reis
Journal:  Infect Immun       Date:  1988-05       Impact factor: 3.441

10.  CD1d-restricted help to B cells by human invariant natural killer T lymphocytes.

Authors:  Grazia Galli; Sandra Nuti; Simona Tavarini; Luisa Galli-Stampino; Claudia De Lalla; Giulia Casorati; Paolo Dellabona; Sergio Abrignani
Journal:  J Exp Med       Date:  2003-04-14       Impact factor: 14.307

View more
  37 in total

1.  Exhausted PD-1+ TOX+ CD8+ T Cells Arise Only in Long-Term Experimental Trypanosoma cruzi Infection.

Authors:  Rosa Isela Gálvez; Thomas Jacobs
Journal:  Front Immunol       Date:  2022-06-03       Impact factor: 8.786

2.  In the Acute Phase of Trypanosoma cruzi Infection, Liver Lymphoid and Myeloid Cells Display an Ambiguous Phenotype Combining Pro- and Anti-Inflammatory Markers.

Authors:  Carina de Lima Pereira Dos Santos; Natalia Vacani-Martins; Cynthia Machado Cascabulho; Mirian Claudia de Souza Pereira; Ian Nicholas Crispe; Andrea Henriques-Pons
Journal:  Front Immunol       Date:  2022-05-26       Impact factor: 8.786

Review 3.  Pathology and Pathogenesis of Chagas Heart Disease.

Authors:  Kevin M Bonney; Daniel J Luthringer; Stacey A Kim; Nisha J Garg; David M Engman
Journal:  Annu Rev Pathol       Date:  2018-10-24       Impact factor: 23.472

4.  Chronic Chagas' Disease: Targeting the Interleukin-2 Axis and Regulatory T Cells in a Condition for Which There Is No Treatment.

Authors:  Jose Mengel; Fabíola Cardillo; Lain Pontes-de-Carvalho
Journal:  Front Microbiol       Date:  2016-05-13       Impact factor: 5.640

5.  Unconventional Pro-inflammatory CD4+ T Cell Response in B Cell-Deficient Mice Infected with Trypanosoma cruzi.

Authors:  Melisa Gorosito Serrán; Jimena Tosello Boari; Facundo Fiocca Vernengo; Cristian G Beccaría; María C Ramello; Daniela A Bermejo; Amelia G Cook; Carola G Vinuesa; Carolina L Montes; Eva V Acosta Rodriguez; Adriana Gruppi
Journal:  Front Immunol       Date:  2017-11-21       Impact factor: 7.561

Review 6.  Biological factors that impinge on Chagas disease drug development.

Authors:  Amanda F Francisco; Shiromani Jayawardhana; Michael D Lewis; Martin C Taylor; John M Kelly
Journal:  Parasitology       Date:  2017-08-23       Impact factor: 3.234

7.  Trypanosoma cruzi load in synanthropic rodents from rural areas in Chile.

Authors:  Esteban Yefi-Quinteros; Catalina Muñoz-San Martín; Antonella Bacigalupo; Juana P Correa; Pedro E Cattan
Journal:  Parasit Vectors       Date:  2018-03-12       Impact factor: 3.876

8.  Targeting Myeloid-Derived Suppressor Cells to Enhance a Trans-Sialidase-Based Vaccine Against Trypanosoma cruzi.

Authors:  Juan Cruz Gamba; Carolina Roldán; Estefanía Prochetto; Giuliana Lupi; Iván Bontempi; Carolina Verónica Poncini; Mónica Vermeulen; Ana Rosa Pérez; Iván Marcipar; Gabriel Cabrera
Journal:  Front Cell Infect Microbiol       Date:  2021-07-06       Impact factor: 5.293

Review 9.  Scrutinizing the Biomarkers for the Neglected Chagas Disease: How Remarkable!

Authors:  Rosa T Pinho; Mariana C Waghabi; Fabíola Cardillo; José Mengel; Paulo R Z Antas
Journal:  Front Immunol       Date:  2016-08-11       Impact factor: 7.561

Review 10.  Regulatory Lymphoid and Myeloid Cells Determine the Cardiac Immunopathogenesis of Trypanosoma cruzi Infection.

Authors:  Manuel Fresno; Núria Gironès
Journal:  Front Microbiol       Date:  2018-03-01       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.